Business Development Manager, Japan (Eurofins Discovery)

Position Summary:

Business Development position will have revenue responsibilities in the assigned territory. The Business Development Manager, Japan will be responsible for both strategic and tactical selling of the entire Eurofins Discovery service and product portfolio utilizing highly consultative and technical sales strategies. Customers include industrial and large academic institutions in the drug discovery industry and CRO’s.

Location:

Field Based, Tokyo or Osaka Preferred

Responsibilities:

• Identify and build business relationships with new prospects as well as with new groups within existing accounts (sales calls, lead follow up, on-site seminars, trade shows, and user meetings).
• Technically competent and knowledgeable on entire Eurofins Discovery service portfolio; ability to offer consultative solutions spanning multiple Eurofins Discovery platforms.
• Communicate with management-level decision makers to structure new deals and build upon existing business relationships.
• Coordinate customer visits with Eurofins Discovery scientists, and specialists.
• Effectively adapt business development plans based on Eurofins Discovery strengths and needs unique to the territory.
• Maintains accurate records of all sales and prospecting activities including sales calls, presentations, closed sales, and follow-up activities within the assigned territory, including the use of CRM Dynamics 365 to maintain accurate records to maximize territory potential.
• Ensure transactions and orders from customers to Client Services/Technical Scientific Support teams are accurate and complete.
• Attend and participate in training meetings at the company’s request.
• Maintain an accurate sales forecast which must be updated weekly.
• Performs other duties as required and assigned.

To perform this job successfully, the individual must be able to perform each essential duty satisfactorily. The requirements below are representative of the knowledge, skill or ability required.

• A minimum education of Bachelor’s degree (B.S.) or above in applicable life science (Pharmacology, Cell Biology or Biochemistry is preferred.)
• Basic knowledge of the drug discovery and development process, especially in the territory.
• Five years of successful technical sales experience or equivalent.
• Good understanding and experience in the preclinical CRO market
• Fluency in discussing science in the local language (Japanese)
• Fluency in spoken and written English
• Self-starter who is a result and success-oriented individual with the proven ability to develop and follow through on sales tasks and plans.
• Excellent interpersonal and relationship management skills.
• Ability to respond effectively to scientific inquiries and quickly address the appropriate internal contacts.
• Trust, Integrity, Respect people, commitment to excellence, customer focus – listen to customers and timely/efficiently feedback, numerate with business acumen, teamwork, etc.
• Frequent travel in Japan to visit customers
• Occasionally travel to USA, EU or Asia for customer’s audit visits, team meeting or training
• No need for visa sponsorship
• Authorized to work in Japan

We support your development! Do you feel you don’t match 100% of the requirements? Don’t hesitate to apply anyway! Eurofins companies are committed to supporting your career development.

We embrace diversity! Eurofins network of companies believe in strength and innovation through diversity, being an Equal Opportunity Employer. We prohibit discrimination against employees or applications based on gender identity and/or expression, race, nationality, age, religion, sexual orientation, disability, and everything else that makes employees of Eurofins companies unique.

Sustainability matters to us!We are well on our way to achieving our objective of carbon neutrality by 2025, through a combination of emission reduction and compensation initiatives. We encourage our laboratory leaders to make sustainable changes at their local level, and in addition to their initiatives we also count on our dedicated carbon reduction team to help us to achieve this goal!

Find out more in our career page: https://careers.eurofins.com/

Company description: Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and our environment safer, healthier and more sustainable. From the food you eat, to the water you drink, to the medicines you rely on, Eurofins laboratories work with the biggest companies in the world to ensure the products they supply are safe, their ingredients are authentic and labelling is accurate.

The Eurofins network of companies is the global leader in food, environment, pharmaceutical and cosmetic product testing and in discovery pharmacology, forensics, advanced material sciences and agroscience contract research services. It is one of the market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, advanced material sciences and in the support of clinical studies, as well as having an emerging global presence in Contract Development and Manufacturing Organisations. It also has a rapidly developing presence in highly specialised and molecular clinical diagnostic testing and in-vitro diagnostic products.

In over 35 years, Eurofins has grown from one laboratory in Nantes, France to 61,000 staff across a decentralised and entrepreneurial network of ca. 900 laboratories in 61 countries. Eurofins companies offer a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products.

In 2022, Eurofins generated total revenues of EUR 6.7 billion, and has been among the best performing stocks in Europe over the past 20 years.

Eurofins is Testing for Life. The Eurofins network of companies believes that it is the global leader in food, environment, pharmaceutical and cosmetic product testing and in discovery pharmacology, forensics, advanced material sciences and agroscience contract research services. It is also one of the market leaders in certain testing and laboratory services for genomics, and in the support of clinical studies, as well as in biopharma contract development and manufacturing. It also has a rapidly developing presence in highly specialised and molecular clinical diagnostic testing and in-vitro diagnostic products.

With over 62,000 staff across a decentralised and entrepreneurial network of ca. 900 laboratories in 61 countries, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of a wide range of products, as well as providing innovative clinical diagnostic testing services and in-vitro diagnostic products.

Eurofins companies’ broad range of services are important for the health and safety of people and our planet. The ongoing investment to become fully digital and maintain the best network of state-of-the-art laboratories and equipment supports our objective to provide our customers with high-quality services, innovative solutions and accurate results in the best possible turnaround time (TAT). Eurofins companies are well positioned to support clients’ increasingly stringent quality and safety standards and the increasing demands of regulatory authorities as well as the evolving requirements of healthcare practitioners around the world.

Eurofins has grown very strongly since its inception and its strategy is to continue expanding its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions.

Shares in Eurofins Scientific are listed on the Euronext Paris Stock Exchange (ISIN FR0014000MR3, Reuters EUFI.PA, Bloomberg ERF FP).